Bryan Gilburg - China

“Manufacturers using chemicals included in the list will need to submit annual usage reports to the TFDA.”

Bryan Gilburg

Managing Director

Come grow with us in the US in Thailand in China in Korea in the Philippines in Taiwan in Hong Kong

Sources and Links

The Thai FDA Updates List of Chemical Pollutants

Published on: August 25th, 2021

Manufacturers Will Need to Report Usage of Certain Chemicals

As chemical pollutants become a growing concern, The Thai FDA has released a document to have medical device regulations comply with the Stockholm Convention on Persistent Organic Pollutants. This announcement establishes rules for gathering reports on chemical substances usage, indicated in the chart below. The full announcement can be found here.

If any of these chemicals are used, the amount of usage should be reported to the Thai FDA at mdregulation@fda.moph.go.th beginning September 2021.

CAS No. 335 -67-1 Perfluorooctanoic acid (PFOA
CAS No. 3825-26-1 Ammonium Perfluorooctanoate
CAS No. 334-95-5 Sodium Perfluorooctanoate
CAS No. 2395-00-8 Potassium Perfluorooctanoate
CAS No. 335-93-3 Silver Perfluorooctanoate
CAS No. 335-66-0 Perfluorooctanoyl Fluoride
CAS No. 376-27-2 Methyl Perfluorooctanoate
CAS No. 3108-24-5 Ethyl Perfluorooctanoate

Come Grow with Us

Asia Actual has offices in Bangkok, and throughout Southeast Asia, staffed by experienced, bilingual regulatory and commercial professionals to address any questions or provide support.  Please contact us if you need regulatory support in the region.

Asia Actual is a regulatory consulting company specializing in helping manufacturers grow their sales through independent license holding, direct fulfillment, and a variety of sales channel support services.

Blog Posts

CDSCO Issues Updates to IVD Classification List in India

The Central Drugs Standard Control Organisation (CDSCO) of India issued a notice (PDF) on October 25, 2023 classifying in-vitro diagnostic (IVD) medical devices under medical device rules. The updates to IVD classification in India include intended use, associated risk, and other parameters.
Read more

Embracing Innovation and Collaboration: Highlights from the 15th CII Global MedTech Summit

On October 6, 2023, a team of enthusiastic members from the AAI (Artificial Intelligence and Innovation) group, including Ashoniya Puri, Sanjay Singh, and Rajat Budhori, had the honor of attending the prestigious 15th CII Global MedTech Summit. Hosted by the Confederation of Indian Industry (CII), one of India's largest industry bodies, this event brought together key players in the MedTech sector, both from India and abroad. The summit revolved around the central theme, "Paving the way for a USD 50 billion MedTech Industry by 2030," signifying a collective vision for the industry's future growth.
Read more

Bangladesh LAUNCHES NEW MEDICAL DEVICE REGULATIONS

On September 18, 2023, The Directorate General of Drug Administration (DGDA) published the Drug and Cosmetics Act 2023 formalizing the regulatory requirements of medical and diagnostic devices in Bangladesh with immediate effect.  A translated version of the document is available on Asia Actual’s website here.  All medical devices now require a Marketing Authorization Certificate to clear Customs and be sold on the market in Bangladesh.
Read more